BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 26613407)

  • 1. Greatwall promotes cell transformation by hyperactivating AKT in human malignancies.
    Vera J; Lartigue L; Vigneron S; Gadea G; Gire V; Del Rio M; Soubeyran I; Chibon F; Lorca T; Castro A
    Elife; 2015 Nov; 4():. PubMed ID: 26613407
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fcp1 phosphatase controls Greatwall kinase to promote PP2A-B55 activation and mitotic progression.
    Della Monica R; Visconti R; Cervone N; Serpico AF; Grieco D
    Elife; 2015 Dec; 4():. PubMed ID: 26653855
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Spatial regulation of greatwall by Cdk1 and PP2A-Tws in the cell cycle.
    Wang P; Larouche M; Normandin K; Kachaner D; Mehsen H; Emery G; Archambault V
    Cell Cycle; 2016; 15(4):528-39. PubMed ID: 26761639
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Greatwall dephosphorylation and inactivation upon mitotic exit is triggered by PP1.
    Ma S; Vigneron S; Robert P; Strub JM; Cianferani S; Castro A; Lorca T
    J Cell Sci; 2016 Apr; 129(7):1329-39. PubMed ID: 26906418
    [TBL] [Abstract][Full Text] [Related]  

  • 5. AKT Regulates Mitotic Progression of Mammalian Cells by Phosphorylating MASTL, Leading to Protein Phosphatase 2A Inactivation.
    Reshi I; Nisa MU; Farooq U; Gillani SQ; Bhat SA; Sarwar Z; Nabi N; Fazili KM; Andrabi S
    Mol Cell Biol; 2020 Apr; 40(10):. PubMed ID: 32123010
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Greatwall-PP2A axis in cell cycle control.
    Wang P; Malumbres M; Archambault V
    Methods Mol Biol; 2014; 1170():99-111. PubMed ID: 24906311
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cell cycle-dependent regulation of Greatwall kinase by protein phosphatase 1 and regulatory subunit 3B.
    Ren D; Fisher LA; Zhao J; Wang L; Williams BC; Goldberg ML; Peng A
    J Biol Chem; 2017 Jun; 292(24):10026-10034. PubMed ID: 28446604
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Greatwall kinase at a glance.
    Castro A; Lorca T
    J Cell Sci; 2018 Oct; 131(20):. PubMed ID: 30355803
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protein phosphatase 2A negatively regulates insulin's metabolic signaling pathway by inhibiting Akt (protein kinase B) activity in 3T3-L1 adipocytes.
    Ugi S; Imamura T; Maegawa H; Egawa K; Yoshizaki T; Shi K; Obata T; Ebina Y; Kashiwagi A; Olefsky JM
    Mol Cell Biol; 2004 Oct; 24(19):8778-89. PubMed ID: 15367694
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PP2A/B55 and Fcp1 regulate Greatwall and Ensa dephosphorylation during mitotic exit.
    Hégarat N; Vesely C; Vinod PK; Ocasio C; Peter N; Gannon J; Oliver AW; Novák B; Hochegger H
    PLoS Genet; 2014 Jan; 10(1):e1004004. PubMed ID: 24391510
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The master Greatwall kinase, a critical regulator of mitosis and meiosis.
    Vigneron S; Robert P; Hached K; Sundermann L; Charrasse S; Labbé JC; Castro A; Lorca T
    Int J Dev Biol; 2016; 60(7-8-9):245-254. PubMed ID: 27759153
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protein phosphatase 1 is essential for Greatwall inactivation at mitotic exit.
    Heim A; Konietzny A; Mayer TU
    EMBO Rep; 2015 Nov; 16(11):1501-10. PubMed ID: 26396231
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The substrate of Greatwall kinase, Arpp19, controls mitosis by inhibiting protein phosphatase 2A.
    Gharbi-Ayachi A; Labbé JC; Burgess A; Vigneron S; Strub JM; Brioudes E; Van-Dorsselaer A; Castro A; Lorca T
    Science; 2010 Dec; 330(6011):1673-7. PubMed ID: 21164014
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Greatwall kinase: a new pathway in the control of the cell cycle.
    Lorca T; Castro A
    Oncogene; 2013 Jan; 32(5):537-43. PubMed ID: 22469975
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of Greatwall kinase in release of mouse oocytes from diplotene arrest.
    Zhao X; Yu D; Feng C; Deng X; Wu D; Jin M; Wang E; Wang X; Yu B
    Dev Growth Differ; 2014 Dec; 56(9):669-78. PubMed ID: 25472593
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MASTL: A novel therapeutic target for Cancer Malignancy.
    Fatima I; Singh AB; Dhawan P
    Cancer Med; 2020 Sep; 9(17):6322-6329. PubMed ID: 32692487
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Suppression of scant identifies Endos as a substrate of greatwall kinase and a negative regulator of protein phosphatase 2A in mitosis.
    Rangone H; Wegel E; Gatt MK; Yeung E; Flowers A; Debski J; Dadlez M; Janssens V; Carpenter AT; Glover DM
    PLoS Genet; 2011 Aug; 7(8):e1002225. PubMed ID: 21852956
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A first generation inhibitor of human Greatwall kinase, enabled by structural and functional characterisation of a minimal kinase domain construct.
    Ocasio CA; Rajasekaran MB; Walker S; Le Grand D; Spencer J; Pearl FM; Ward SE; Savic V; Pearl LH; Hochegger H; Oliver AW
    Oncotarget; 2016 Nov; 7(44):71182-71197. PubMed ID: 27563826
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Boolean modeling identifies Greatwall/MASTL as an important regulator in the AURKA network of neuroblastoma.
    Dahlhaus M; Burkovski A; Hertwig F; Mussel C; Volland R; Fischer M; Debatin KM; Kestler HA; Beltinger C
    Cancer Lett; 2016 Feb; 371(1):79-89. PubMed ID: 26616283
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Loss of human Greatwall results in G2 arrest and multiple mitotic defects due to deregulation of the cyclin B-Cdc2/PP2A balance.
    Burgess A; Vigneron S; Brioudes E; Labbé JC; Lorca T; Castro A
    Proc Natl Acad Sci U S A; 2010 Jul; 107(28):12564-9. PubMed ID: 20538976
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.